Ignite Creation Date:
2024-05-06 @ 3:52 PM
Last Modification Date:
2024-10-26 @ 1:58 PM
Study NCT ID:
NCT04784221
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-07-27
First Post:
2021-03-02
Brief Title:
Nanoparticles and Hypofractionated Protontherapy for Reirradiation of Pantumor Relapse
Sponsor:
Centre Francois Baclesse
Organization:
Centre Francois Baclesse
Study Overview
Official Title:
Nanoparticles and Hypofractionated Protontherapy for Reirradiation of Pantumor Relapse NANOPRO a Non-randomized Phase II Study
Status:
NOT_YET_RECRUITING
Status Verified Date:
2023-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
NANOPRO
Brief Summary:
This is a prospective multicenter non-randomized phase II study proton therapy with nanoparticles based on polysiloxane and gadolinium chelates injectable intravenously
Detailed Description:
This is a prospective multicenter non-randomized phase II study proton therapy with nanoparticles based on polysiloxane and gadolinium chelates injectable intravenously in recurrent tumors
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None